{"filings":[{"id":1370396,"accession_number":"0001104659-26-079606","cik":926326,"company_name":"OMNICELL, INC.","ticker":"OMCL","form_type":"8-K","filed_at":"2026-07-01T12:27:47+00:00","items":["5.02","9.01"],"status":"ready","headline":"Omnicell appoints Nnamdi Njoku as President; Lipps remains CEO and Chairman","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Nnamdi Njoku appointed President of Omnicell effective July 1, 2026, while retaining COO role.","Randall Lipps steps down as President but continues as CEO and Chairman of the Board; no compensation change.","Njoku receives one-time RSU award of ~$500k vesting over three years; base salary unchanged at $661k, target bonus 100%.","Njoku to lead growth strategy, launch of Titan XT automated dispensing system and OmniSphere platform.","Njoku previously served as EVP and COO since Oct 2024; prior roles at Medtronic, Zimmer Biomet."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"market_cap_usd":1961050468.1777778,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":668876,"accession_number":"0001104659-26-066316","cik":926326,"company_name":"OMNICELL, INC.","ticker":"OMCL","form_type":"8-K","filed_at":"2026-05-26T20:40:24+00:00","items":["5.02","5.07","5.03","9.01"],"status":"ready","headline":"Omnicell shareholders approve 1.6M share increase to equity plan and officer exculpation amendment","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Stockholders approved amendment to 2009 Equity Incentive Plan adding 1,600,000 shares (35.2M for, 1.5M against).","Approved certificate amendment to exculpate certain officers from personal liability as permitted by Delaware law.","Elected three Class I directors: Joanne B. Bauer, Robin G. Seim, Eileen J. Voynick for terms until 2029.","Advisory say-on-pay vote passed with 35.3M for, 1.5M against; ratification of Deloitte & Touche as auditor for FY2026 also approved."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"market_cap_usd":1961050468.1777778,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":99839,"accession_number":"0000926326-26-000009","cik":926326,"company_name":"OMNICELL, INC.","ticker":"OMCL","form_type":"8-K","filed_at":"2026-04-28T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Omnicell Q1 revenue $310M (+15% YoY); raises FY2026 non-GAAP EBITDA/EPS guidance","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["GAAP net income $11M ($0.25/diluted) vs loss of $7M ($0.15 loss) in Q1 2025.","Non-GAAP net income $25M ($0.55/diluted); Non-GAAP EBITDA $45M, vs $24M a year ago.","Operating cash flow $55M, more than double the $26M in Q1 2025.","FY2026 revenue guidance raised to $1.215B–$1.255B; non-GAAP EPS raised to $1.80–$2.00.","Customer engagement underway for Titan XT and OmniSphere platform evolution."],"consensus_eps_estimate":null,"consensus_eps_actual":0.25,"consensus_revenue_estimate":null,"consensus_revenue_actual":309880000.0,"consensus_period":"2026-Q1","consensus_source":"xbrl_only","sentiment":"positive","materiality_score":0.8,"calibrated_materiality_score":0.8,"market_cap_usd":1961050468.1777778,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":116092,"accession_number":"0000926326-26-000003","cik":926326,"company_name":"OMNICELL, INC.","ticker":"OMCL","form_type":"8-K","filed_at":"2026-02-05T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Omnicell Q4 rev $314M (+2% YoY), GAAP net loss $0.05/sh; FY26 revenue guide $1.215-1.255B","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Q4 total revenues $314M (+2% YoY); full-year 2025 rev $1.185B (+7% YoY).","GAAP net loss Q4 $2M ($0.05 diluted loss) vs net income $16M ($0.34) in Q4 2024.","Non-GAAP net income Q4 $18M ($0.40) vs $28M ($0.60) YoY; FY25 non-GAAP EPS $1.62.","FY2025 product bookings $535M (-4% YoY); ARR $635.6M (+9.6%); product backlog $640.3M.","Launched Titan XT dispensing system at ASHP Midyear; guides FY26 rev $1.215-1.255B, Non-GAAP EBITDA $145-160M."],"consensus_eps_estimate":null,"consensus_eps_actual":0.04,"consensus_revenue_estimate":null,"consensus_revenue_actual":1184845000.0,"consensus_period":"2025-FY","consensus_source":"xbrl_only","sentiment":"neutral","materiality_score":0.8,"calibrated_materiality_score":0.8,"market_cap_usd":1961050468.1777778,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":132529,"accession_number":"0001104659-25-119083","cik":926326,"company_name":"OMNICELL, INC.","ticker":"OMCL","form_type":"8-K","filed_at":"2025-12-08T23:59:59+00:00","items":["7.01","9.01"],"status":"ready","headline":"Omnicell launches Titan XT automated dispensing system powered by OmniSphere cloud platform","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Launch of Omnicell Titan XT, a next-gen automated dispensing system for autonomous medication management, available now in US.","Powered by OmniSphere cloud platform, unifying automation and AI-enabled intelligence for enterprise-wide medication management.","Features include DynamicRestock guided workflows, centralized inventory control, and AI predictive stock risk analytics.","Designed to improve pharmacy control and nursing confidence with FiveRights safeguards and simplified medication retrieval.","International availability anticipated in later 2026; ongoing OmniSphere releases beginning early 2027."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.6,"calibrated_materiality_score":0.6,"market_cap_usd":1961050468.1777778,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":132528,"accession_number":"0000926326-25-000029","cik":926326,"company_name":"OMNICELL, INC.","ticker":"OMCL","form_type":"8-K","filed_at":"2025-10-30T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Omnicell Q3 rev $311M (+10% YoY), beats guidance; raises FY2025 outlook","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Q3 revenue $311M (+10% YoY); GAAP EPS $0.12, non-GAAP EPS $0.51; non-GAAP EBITDA $41M.","Results exceeded prior Q3 guidance; full-year revenue guidance raised to $1.177B-$1.187B.","Non-GAAP EBITDA guidance raised to $140M-$146M; non-GAAP EPS raised to $1.63-$1.73.","Repaid $175M convertible notes; repurchased ~1.987M shares for $62M during Q3.","Cash $180M, debt $167M; operating cash flow $28M in Q3."],"consensus_eps_estimate":null,"consensus_eps_actual":0.09,"consensus_revenue_estimate":null,"consensus_revenue_actual":870861000.0,"consensus_period":"2025-Q3","consensus_source":"xbrl_only","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":1961050468.1777778,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":132527,"accession_number":"0000926326-25-000026","cik":926326,"company_name":"OMNICELL, INC.","ticker":"OMCL","form_type":"8-K","filed_at":"2025-10-06T23:59:59+00:00","items":["5.03","9.01"],"status":"ready","headline":"Omnicell adopts amended bylaws with enhanced stockholder nomination and proposal procedures","summary_kind":"llm","event_type":"other","confidence":"high","bullets":["Board adopted fourth amended and restated bylaws effective September 30, 2025.","Enhanced disclosure requirements for stockholder director nominations and proposals (excluding Rule 14a-8).","Addresses Rule 14a-19 requirements and clarifies personal jurisdiction consent.","Includes ministerial and conforming updates."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.25,"calibrated_materiality_score":0.25,"market_cap_usd":1961050468.1777778,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":149060,"accession_number":"0001104659-25-082526","cik":926326,"company_name":"OMNICELL, INC.","ticker":"OMCL","form_type":"8-K","filed_at":"2025-08-25T23:59:59+00:00","items":["5.02","9.01"],"status":"ready","headline":"Omnicell appoints Baird Radford as CFO effective Aug 26; Etta steps down","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Baird Radford appointed EVP and CFO effective August 26, 2025; succeeds Nchacha Etta who steps down.","Radford brings 30+ years in healthcare/tech; most recently CFO at Allakos; also CFO at HeartFlow.","Nchacha Etta will remain as executive adviser through November 15, 2025 to ensure smooth transition.","Compensation: base salary $525,000; one-time RSU grant of $1,000,000; annual equity target of $2,300,000 in RSUs and PSUs."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"market_cap_usd":1961050468.1777778,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":149059,"accession_number":"0000926326-25-000016","cik":926326,"company_name":"OMNICELL, INC.","ticker":"OMCL","form_type":"8-K","filed_at":"2025-07-31T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Omnicell Q2 2025 revenue $291M (+5% YoY), beats guidance; raises FY2025 outlook","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Total revenues $291M (+5% YoY); GAAP EPS $0.12, non-GAAP EPS $0.45.","Non-GAAP EBITDA $38M; operating cash flow $43M in Q2 2025.","FY2025 total revenue guidance raised to $1.130B-$1.160B; non-GAAP EPS raised to $1.40-$1.65.","Product bookings guidance reaffirmed at $500M-$550M; ARR $610M-$630M.","Cash $399M, total debt $342M; $350M revolver undrawn as of June 30."],"consensus_eps_estimate":null,"consensus_eps_actual":-0.03,"consensus_revenue_estimate":null,"consensus_revenue_actual":560230000.0,"consensus_period":"2025-Q2","consensus_source":"xbrl_only","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":1961050468.1777778,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":168032,"accession_number":"0001104659-25-056908","cik":926326,"company_name":"OMNICELL, INC.","ticker":"OMCL","form_type":"8-K","filed_at":"2025-06-05T23:59:59+00:00","items":["5.02","9.01"],"status":"ready","headline":"Omnicell CFO Nchacha Etta separation agreement provides $925K severance, extended departure to Nov 15, 2025","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["CFO Nchacha Etta to depart; employment extended through Nov 15, 2025, or until successor appointed.","Severance of $925,062 (12 months base salary + target bonus) plus $10,000 for outplacement.","Additional one year vesting credit on equity awards; 12 months continued financial planning ($16k/year max).","Etta to serve as Special Advisor to CEO after successor named or transition to advisory role.","Agreement includes standard restrictive covenants and general release of claims."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.65,"calibrated_materiality_score":0.65,"market_cap_usd":1961050468.1777778,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":168031,"accession_number":"0001104659-25-052464","cik":926326,"company_name":"OMNICELL, INC.","ticker":"OMCL","form_type":"8-K","filed_at":"2025-05-23T23:59:59+00:00","items":["5.02","5.07","9.01"],"status":"ready","headline":"Omnicell stockholders approve 1.75M share increase to 2009 equity plan; re-elect directors","summary_kind":"llm","event_type":"other","confidence":"high","bullets":["Stockholders elected Edward P. Bousa, Mary Garrett, and Bruce E. Scott as Class III directors for three-year terms.","Amendment to 2009 Equity Incentive Plan approved: adds 1,750,000 authorized shares to common stock pool.","Say-on-pay advisory vote passed with 35.78M for vs 1.72M against; auditor Deloitte ratified with 41.53M for.","Broker non-votes of 4.28M recorded on director election and advisory items.","Plan amendment filed as Exhibit 10.1; full terms incorporate proxy statement Appendix A."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.4,"calibrated_materiality_score":0.4,"market_cap_usd":1961050468.1777778,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":168030,"accession_number":"0001104659-25-051854","cik":926326,"company_name":"OMNICELL, INC.","ticker":"OMCL","form_type":"8-K","filed_at":"2025-05-22T23:59:59+00:00","items":["7.01","9.01"],"status":"ready","headline":"Omnicell raises Q2 and FY2025 profit outlook on tariff relief; authorizes $75M share buyback","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Q2 Non-GAAP EBITDA guidance raised to $25-31M (from $22-30M); Non-GAAP EPS raised to $0.24-0.34 (from $0.19-0.32).","FY2025 Non-GAAP EBITDA low end raised to $120M (from $100M); Non-GAAP EPS low end raised to $1.30 (from $1.00).","Revenue guidance unchanged: FY total revenue $1.105-1.155B, Q2 total $270-280M.","Board authorized new $75M stock repurchase program with no expiration; $2.7M remains under prior 2016 program.","Improvement attributed to U.S. tariff reduction on China imports from 145% to 30% for 90 days."],"consensus_eps_estimate":null,"consensus_eps_actual":-0.15,"consensus_revenue_estimate":null,"consensus_revenue_actual":269668000.0,"consensus_period":"2025-Q1","consensus_source":"xbrl_only","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":1961050468.1777778,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":168029,"accession_number":"0000926326-25-000006","cik":926326,"company_name":"OMNICELL, INC.","ticker":"OMCL","form_type":"8-K","filed_at":"2025-05-06T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Omnicell Q1 revenue $270M (+10% YoY); non-GAAP EPS $0.26 vs $0.03; FY guidance cut","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Total revenues $270M, up 10% YoY; GAAP net loss $7M ($0.15) vs loss $16M ($0.34) YoY.","Non-GAAP net income $12M ($0.26) vs $1M ($0.03); non-GAAP EBITDA $24M vs $11M.","Operating cash flow $26M in Q1 2025 vs $50M; cash and equivalents $387M.","FY2025 guidance lowered: non-GAAP EBITDA $100M-$145M, non-GAAP EPS $1.00-$1.65 due to tariff uncertainty.","Product bookings target $500M-$550M; annual recurring revenue guidance $610M-$630M for 2025."],"consensus_eps_estimate":null,"consensus_eps_actual":-0.15,"consensus_revenue_estimate":null,"consensus_revenue_actual":269668000.0,"consensus_period":"2025-Q1","consensus_source":"xbrl_only","sentiment":"neutral","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":1961050468.1777778,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":185260,"accession_number":"0001104659-25-022797","cik":926326,"company_name":"OMNICELL, INC.","ticker":"OMCL","form_type":"8-K","filed_at":"2025-03-12T23:59:59+00:00","items":["5.02","7.01","9.01"],"status":"ready","headline":"Omnicell CFO Nchacha Etta to step down by Sept 2025; company reiterates 2025 guidance","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Nchacha Etta steps down as EVP & CFO effective Sept 15, 2025 or upon successor appointment; national search underway.","Departure not due to any disagreement with the company on operations, policies, or financial reporting.","Company reiterates Q1 and full year 2025 guidance as provided on Feb 6, 2025 earnings release.","Etta will continue in role to assist transition until successor named."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.55,"calibrated_materiality_score":0.55,"market_cap_usd":1961050468.1777778,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":185259,"accession_number":"0001104659-25-020354","cik":926326,"company_name":"OMNICELL, INC.","ticker":"OMCL","form_type":"8-K","filed_at":"2025-03-04T23:59:59+00:00","items":["5.02","9.01"],"status":"ready","headline":"Omnicell enters new CEO employment agreement with Randall Lipps through Dec 2027","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Base salary of at least $833,000; annual cash bonus target no less than 125% of base salary.","Annual long-term incentive award grant date fair value of no less than $6,375,000.","Term through December 31, 2027; severance includes 3x base plus bonus if terminated before 2027 LTIP grant.","Enhanced severance for termination within Change in Control Protection Period (2x base plus bonus, COBRA cash payment).","Continued vesting for time-based RSUs upon retirement or end of term if at least 9 months after grant."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.55,"calibrated_materiality_score":0.55,"market_cap_usd":1961050468.1777778,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":185258,"accession_number":"0001104659-25-009872","cik":926326,"company_name":"OMNICELL, INC.","ticker":"OMCL","form_type":"8-K","filed_at":"2025-02-06T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Omnicell Q4 revenue $307M (+19% YoY); 2025 guides ARR $610-630M, product bookings $500-550M","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Q4 total revenues $307M, up 19% YoY; GAAP net income $16M ($0.34 diluted) vs loss of $14M in Q4 2023.","Full year 2024 revenues $1.112B, down 3% YoY; GAAP net income $13M ($0.27) vs loss of $20M in 2023.","Bookings for 2024 were $923M, up 8% YoY; backlog $1.20B. Introduced new metrics: product bookings $558M, ARR $580M.","2025 guidance: total revenues $1.105-1.155B; non-GAAP EBITDA $140-155M; non-GAAP EPS $1.65-1.85.","Issued $172.5M of 1.00% convertible notes due 2029; repurchased $400M of 0.25% notes due 2025."],"consensus_eps_estimate":null,"consensus_eps_actual":0.27,"consensus_revenue_estimate":null,"consensus_revenue_actual":1112238000.0,"consensus_period":"2024-FY","consensus_source":"xbrl_only","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":1961050468.1777778,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":201848,"accession_number":"0001104659-24-122635","cik":926326,"company_name":"OMNICELL, INC.","ticker":"OMCL","form_type":"8-K","filed_at":"2024-11-25T23:59:59+00:00","items":["1.01","2.03","3.02","8.01","9.01"],"status":"ready","headline":"Omnicell issues $172.5M 1.00% convertible notes due 2029, repurchases $400M of 2025 notes","summary_kind":"llm","event_type":"debt","confidence":"high","bullets":["Priced $150M (upsized to $172.5M) of 1.00% Convertible Senior Notes due 2029; conversion price ~$57.25 (35% premium).","Used $166M net proceeds plus cash to repurchase $400M of outstanding 0.25% 2025 notes for ~$391.2M.","Entered convertible note hedge on ~3.0M shares at $57.25 and sold warrants at $84.82 to offset dilution.","Notes mature Dec 1, 2029; redeemable after Dec 6, 2027 if stock price ≥130% of conversion price for 20 of 30 days.","Net cost of hedge/warrant transactions ~$15.1M; unwind of prior hedges on 2025 notes resulted in net $0.7M payment."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.8,"calibrated_materiality_score":0.8,"market_cap_usd":1961050468.1777778,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":201847,"accession_number":"0001104659-24-120206","cik":926326,"company_name":"OMNICELL, INC.","ticker":"OMCL","form_type":"8-K","filed_at":"2024-11-18T23:59:59+00:00","items":["1.01","8.01","9.01"],"status":"ready","headline":"Omnicell proposes $150M convertible notes due 2029; to repurchase up to $400M of 2025 notes","summary_kind":"llm","event_type":"debt","confidence":"high","bullets":["Offers $150M aggregate principal of 0.25% Convertible Senior Notes due 2029, plus $22.5M greenshoe.","Proceeds used to repurchase up to $400M of existing 0.25% 2025 notes via privately negotiated transactions.","Enters convertible note hedge and warrant transactions to reduce dilution and offset conversion obligations.","Amended credit agreement: springing maturity triggered only if >$200M of 2025 notes remain outstanding 91 days before maturity.","Notes will be unsecured senior obligations, mature Dec 1, 2029; interest rate and conversion terms set at pricing."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.65,"calibrated_materiality_score":0.65,"market_cap_usd":1961050468.1777778,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":201846,"accession_number":"0000926326-24-000030","cik":926326,"company_name":"OMNICELL, INC.","ticker":"OMCL","form_type":"8-K","filed_at":"2024-10-30T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Omnicell Q3 revenue $282M (-5% YoY); raises FY2024 non-GAAP EBITDA & EPS guidance","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Q3 GAAP net income $9M ($0.19/diluted) vs. $6M ($0.12) YoY; non-GAAP EPS $0.56 vs. $0.62.","Total revenues $282M, down 5% YoY due to health system headwinds and XT Series cycle timing.","FY2024 guidance raised: non-GAAP EBITDA $129-134M, non-GAAP EPS $1.65-1.72.","Appointed Nnamdi Njoku as EVP & COO; cash $571M, $350M revolver undrawn.","Q4 2024 revenue guidance $295-305M; non-GAAP Q4 EPS $0.55-0.62."],"consensus_eps_estimate":null,"consensus_eps_actual":-0.07,"consensus_revenue_estimate":null,"consensus_revenue_actual":805359000.0,"consensus_period":"2024-Q3","consensus_source":"xbrl_only","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":1961050468.1777778,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":217872,"accession_number":"0001104659-24-102781","cik":926326,"company_name":"OMNICELL, INC.","ticker":"OMCL","form_type":"8-K","filed_at":"2024-09-25T23:59:59+00:00","items":["5.02","9.01"],"status":"ready","headline":"Omnicell appoints Nnamdi Njoku as EVP and COO, effective Oct 7","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Nnamdi Njoku named EVP and Chief Operating Officer; role reports to CEO Randall Lipps.","Njoku previously President at Zimmer Biomet and SVP/President at Medtronic; ~25 years experience.","Initial base salary $645,000; eligible for Q4 special bonus of $161,250 and one-time equity award of ~$2.25M RSUs.","2025 equity awards include RSUs of ~$1.5M and PSUs of ~$1.5M based on relative TSR over one year.","Eligible for Executive Bonus Plan with target cash bonus of 100% of base salary and severance benefits."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.55,"calibrated_materiality_score":0.55,"market_cap_usd":1961050468.1777778,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":217871,"accession_number":"0000926326-24-000024","cik":926326,"company_name":"OMNICELL, INC.","ticker":"OMCL","form_type":"8-K","filed_at":"2024-08-01T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Omnicell Q2 revenue $277M, non-GAAP EPS $0.51; raises FY 2024 guidance","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["GAAP net income $4M ($0.08 diluted); non-GAAP net income $24M ($0.51 diluted).","Total revenue $277M, down 7% YoY; product rev $610-630M guided for FY2024.","Non-GAAP EBITDA $40M in Q2; FY2024 non-GAAP EBITDA guidance raised to $105-125M.","Cash and equivalents $557M; debt $571M; $350M revolver undrawn.","Q3 2024 guidance: rev $275-285M, non-GAAP EPS $0.34-0.44."],"consensus_eps_estimate":null,"consensus_eps_actual":-0.26,"consensus_revenue_estimate":null,"consensus_revenue_actual":522939000.0,"consensus_period":"2024-Q2","consensus_source":"xbrl_only","sentiment":"positive","materiality_score":0.65,"calibrated_materiality_score":0.65,"market_cap_usd":1961050468.1777778,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":237776,"accession_number":"0000926326-24-000019","cik":926326,"company_name":"OMNICELL, INC.","ticker":"OMCL","form_type":"8-K/A","filed_at":"2024-06-04T23:59:59+00:00","items":["5.02"],"status":"ready","headline":"Omnicell extends CAO Joseph Spears retirement to June 30, 2024","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Spears originally set to retire May 31, 2024; new date is June 30, 2024.","He remains Senior VP, Chief Accounting Officer and executive adviser during transition.","Filing amends prior 8-K dated February 29, 2024; no other changes."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.2,"calibrated_materiality_score":0.2,"market_cap_usd":1961050468.1777778,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":237778,"accession_number":"0001104659-24-065130","cik":926326,"company_name":"OMNICELL, INC.","ticker":"OMCL","form_type":"8-K","filed_at":"2024-05-24T23:59:59+00:00","items":["5.02","5.07","9.01"],"status":"ready","headline":"Omnicell annual meeting results: equity plan amendment approved, directors re-elected, auditor ratified","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Stockholders approved amendment to 2009 Equity Incentive Plan, adding 2,462,000 shares to authorized pool.","Re-elected Class II directors Randall A. Lipps, Mark W. Parrish, and Kaushik Ghoshal.","Advisory vote to approve named executive officer compensation passed with ~36.9M for, ~2.65M against.","Ratified Deloitte & Touche as independent auditor for fiscal 2024 with ~42.7M for."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.3,"calibrated_materiality_score":0.3,"market_cap_usd":1961050468.1777778,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":237777,"accession_number":"0000926326-24-000012","cik":926326,"company_name":"OMNICELL, INC.","ticker":"OMCL","form_type":"8-K","filed_at":"2024-05-02T23:59:59+00:00","items":["2.02","2.05","9.01"],"status":"ready","headline":"Omnicell Q1 revenues down 15% to $246M, GAAP net loss $0.34/sh; initiates wind-down of Medimat RDS","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Q1 GAAP revenues $246M (-15% YoY); GAAP net loss $16M ($0.34/sh) vs loss $15M ($0.33/sh) last year.","Non-GAAP net income $1M ($0.03/sh); non-GAAP EBITDA $11M, down from $27M in Q1 2023.","Management commits to wind down Medimat RDS product line; expects to cut >80 employees and close Bochum, Germany facility.","Estimated nonrecurring charges $15-20M ($10-13M cash); $1.6M impairment in Q4 2023 and $3.3M severance in Q1 2024 already recorded.","Full-year 2024 guidance unchanged: revenues $1.045-1.120B, non-GAAP EPS $0.90-1.40, non-GAAP EBITDA $90-120M."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"negative","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":1961050468.1777778,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":255290,"accession_number":"0001104659-24-029356","cik":926326,"company_name":"OMNICELL, INC.","ticker":"OMCL","form_type":"8-K","filed_at":"2024-02-29T23:59:59+00:00","items":["5.02"],"status":"ready","headline":"Omnicell appoints Brian Nutt as Chief Accounting Officer; Joseph Spears to retire May 31, 2024","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Joseph Spears to retire as SVP, Chief Accounting Officer effective May 31, 2024; will remain as executive adviser until then.","Brian Nutt appointed VP, Chief Accounting Officer, effective March 18, 2024; will become principal accounting officer.","Nutt previously served as VP and Controller at Labcorp and CAO of Covance, with prior roles at MedPointe and KPMG.","Spears' departure is not due to any disagreement with the company on operations, policies, or practices."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.35,"calibrated_materiality_score":0.35,"market_cap_usd":1961050468.1777778,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":255289,"accession_number":"0000926326-24-000005","cik":926326,"company_name":"OMNICELL, INC.","ticker":"OMCL","form_type":"8-K","filed_at":"2024-02-08T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Omnicell FY2023 rev $1.147B (-11% YoY), GAAP net loss $0.45/sh; FY2024 guidance below prior year","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["FY2023 total revenue $1.147B, down 11% YoY; GAAP net loss $20M ($0.45/sh) vs prior year GAAP net income $6M.","Non-GAAP net income FY2023 $87M ($1.91/sh), down from $136M ($3.00/sh) in 2022; non-GAAP EBITDA $138M, down from $193M.","Total bookings 2023 $854M, down 19% YoY from $1.054B, driven by lower Advanced Services orders.","Cash and equivalents $468M; total debt $570M; operating cash flow $181M for FY2023; free cash flow $126M.","FY2024 guidance: rev $1.045-1.120B, non-GAAP EPS $0.90-1.40, bookings $750M-$875M; Q1 2024 rev $232-242M, non-GAAP EPS ($0.10)-$0.00."],"consensus_eps_estimate":null,"consensus_eps_actual":-0.45,"consensus_revenue_estimate":null,"consensus_revenue_actual":1147112000.0,"consensus_period":"2023-FY","consensus_source":"xbrl_only","sentiment":"negative","materiality_score":0.8,"calibrated_materiality_score":0.8,"market_cap_usd":1961050468.1777778,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":255288,"accession_number":"0000926326-24-000002","cik":926326,"company_name":"OMNICELL, INC.","ticker":"OMCL","form_type":"8-K","filed_at":"2024-01-11T23:59:59+00:00","items":["5.02","7.01","8.01","9.01"],"status":"ready","headline":"Omnicell elects Eileen Voynick to Board; Sara White resigns; Vance Moore not standing for reelection","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Sara White resigned as director effective Jan 5, 2024, for personal reasons; no disagreement with company.","Eileen Voynick elected Class I director, effective Jan 5, 2024, filling White's vacancy; she is independent.","Vance Moore will not stand for reelection at the 2024 annual meeting; no disagreement cited.","Board size reduced from 10 to 9 directors, effective at the 2024 annual meeting, by reducing Class II directors.","Voynick has over 30 years experience in healthcare tech, software, and global sales; previously CEO of Sparta Systems."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.35,"calibrated_materiality_score":0.35,"market_cap_usd":1961050468.1777778,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":272764,"accession_number":"0000926326-23-000043","cik":926326,"company_name":"OMNICELL, INC.","ticker":"OMCL","form_type":"8-K","filed_at":"2023-11-09T23:59:59+00:00","items":["5.02","9.01"],"status":"ready","headline":"Omnicell EVP & Chief Commercial Officer Seidelmann departs; $868K severance","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Scott P. Seidelmann separated Nov 3, 2023; had transitioned to Special Adviser to CEO on June 1.","Receives lump-sum cash severance of $868,490 (12 months base salary + target MBO).","Accelerated vesting of RSUs/PSUs that would have vested within 12 months post-separation.","Option exercise period extended to 24 months or original expiration, whichever earlier.","Also gets 12 months COBRA premium payments, up to $10K outplacement, and up to $16K/yr financial planning."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"market_cap_usd":1961050468.1777778,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":272763,"accession_number":"0001104659-23-113604","cik":926326,"company_name":"OMNICELL, INC.","ticker":"OMCL","form_type":"8-K","filed_at":"2023-11-02T23:59:59+00:00","items":["2.02","2.05","7.01","9.01"],"status":"ready","headline":"Omnicell Q3 rev $299M (-14% YoY); non-GAAP EPS $0.62; cuts FY23 guidance; plans 7% RIF","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["GAAP revenue $299M (-14% YoY); net income $6M ($0.12 diluted) vs $17M ($0.37) in Q3 2022.","Non-GAAP net income $28M ($0.62 diluted) vs $45M ($1.00) in Q3 2022; non-GAAP EBITDA $41M vs $61M.","Full year 2023 guidance cut: total revenue $1.135B-$1.155B; non-GAAP EPS $1.65-$1.80; Q4 rev $247M-$267M.","Headcount reduction of >230 employees (~7% of workforce); expects $12M-$18M restructuring charges.","Annualized cost savings of $45M-$55M, ~75% in operating expenses; majority realized starting Q1 2024."],"consensus_eps_estimate":null,"consensus_eps_actual":-0.13,"consensus_revenue_estimate":null,"consensus_revenue_actual":888265000.0,"consensus_period":"2023-Q3","consensus_source":"xbrl_only","sentiment":"negative","materiality_score":0.85,"calibrated_materiality_score":0.85,"market_cap_usd":1961050468.1777778,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":272762,"accession_number":"0000926326-23-000039","cik":926326,"company_name":"OMNICELL, INC.","ticker":"OMCL","form_type":"8-K","filed_at":"2023-10-16T23:59:59+00:00","items":["1.01","2.03","9.01"],"status":"ready","headline":"Omnicell enters $350M revolver, down from $500M; includes incremental facility","summary_kind":"llm","event_type":"debt","confidence":"high","bullets":["Five-year revolving credit facility of $350M, downsized from $500M in prior agreement.","Uncommitted incremental loan facility up to $250M plus 100% of adjusted EBITDA.","Maturity on fifth anniversary with springing maturity tied to 0.25% convertible notes due 2025.","Proceeds for working capital, potential acquisitions, and general corporate purposes.","Option within 18 months to adopt ESG amendment adjusting margins based on sustainability KPIs."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.55,"calibrated_materiality_score":0.55,"market_cap_usd":1961050468.1777778,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":272761,"accession_number":"0000926326-23-000037","cik":926326,"company_name":"OMNICELL, INC.","ticker":"OMCL","form_type":"8-K","filed_at":"2023-10-05T23:59:59+00:00","items":["5.02","9.01"],"status":"ready","headline":"Omnicell extends Seidelmann's exit to Nov 3; Mellon gets $760K severance","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Scott Seidelmann's separation as EVP & Chief Commercial Officer moved from Oct 1 to Nov 3, 2023; he remains an executive adviser.","Christine Mellon separated Oct 1, 2023; receives $760,000 lump sum (12 months salary plus target bonus) plus $15,000 for outplacement.","Mellon also gets 12 months of COBRA premium payments and accelerated vesting of restricted stock units that would vest within 12 months post-separation.","Both departures were part of previously disclosed transition plans; no immediate impact on executive leadership structure."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"market_cap_usd":1961050468.1777778,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":289599,"accession_number":"0000926326-23-000035","cik":926326,"company_name":"OMNICELL, INC.","ticker":"OMCL","form_type":"8-K","filed_at":"2023-08-16T23:59:59+00:00","items":["5.02"],"status":"ready","headline":"Omnicell board rejects director Seim's resignation, removes him from audit committee","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Seim received majority withheld votes at May 2023 annual meeting and submitted resignation.","Board rejected resignation after stockholder outreach but removed Seim as Audit Committee chair and member.","Mark W. Parrish appointed Audit Committee chair; Bruce E. Scott appointed to committee.","Audit Committee now composed of Parrish (chair), Bousa, and Scott; all deemed independent.","Board determined Parrish qualifies as audit committee financial expert."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.4,"calibrated_materiality_score":0.4,"market_cap_usd":1961050468.1777778,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":289598,"accession_number":"0000926326-23-000033","cik":926326,"company_name":"OMNICELL, INC.","ticker":"OMCL","form_type":"8-K","filed_at":"2023-08-10T23:59:59+00:00","items":["5.02","9.01"],"status":"ready","headline":"Omnicell CFO Peter Kuipers terminated without cause; severance includes $898K lump sum","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["CFO Peter J. Kuipers terminated without cause effective Aug 1, 2023; separation agreement signed Aug 4.","Severance: $898,320 lump sum (12 months base salary + target MBO), plus COBRA premiums for 12 months and $10K outplacement.","Equity: RSUs and PSUs continue vesting for 12 months post-separation; option exercise period extended to 24 months.","Kuipers remains eligible for 2023 MBO bonus for Q1-Q3 under normal program terms.","Non-solicitation of employees and confidentiality obligations reaffirmed; cooperation obligation for 24 months."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"negative","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":1961050468.1777778,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":289597,"accession_number":"0000926326-23-000029","cik":926326,"company_name":"OMNICELL, INC.","ticker":"OMCL","form_type":"8-K","filed_at":"2023-08-03T23:59:59+00:00","items":["5.02","9.01"],"status":"ready","headline":"Omnicell adopts new Executive Severance Plan with enhanced CIC benefits for named officers","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Plan approved July 30, 2023, covers CEO, EVPs, and SVP (Nchacha Etta, Corey Manley, etc.)","Severance multiples: CEO gets 1.5x base+target outside CIC, 2x inside; EVPs get 1x/1.5x","CIC Protection Period extends 6 months before to 24 months after change in control","Benefits include cash, COBRA subsidies (12-24 months), outplacement, and up to $15k legal fee reimbursement","Plan supersedes prior severance and change-in-control benefit plans"],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"market_cap_usd":1961050468.1777778,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":289596,"accession_number":"0000926326-23-000027","cik":926326,"company_name":"OMNICELL, INC.","ticker":"OMCL","form_type":"8-K","filed_at":"2023-08-01T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Omnicell Q2 revenue $299M (-10% YoY); non-GAAP EPS $0.57 beats guidance; FY outlook $1.16-1.20B","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["GAAP revenue $299M (-10% YoY); GAAP EPS $0.08; non-GAAP EPS $0.57 (beat guidance).","Non-GAAP EBITDA $47M vs $56M YoY; operating cash flow $73M vs -$10M YoY.","FY 2023 revenue guidance $1.16B-$1.20B; non-GAAP EPS $1.75-$2.00; bookings at low end of $1.0-$1.1B.","Q3 2023 guidance: revenue $290M-$300M; non-GAAP EPS $0.42-$0.52.","Cash $399M; total debt $568M; no revolver draw; availability $418M."],"consensus_eps_estimate":null,"consensus_eps_actual":-0.26,"consensus_revenue_estimate":null,"consensus_revenue_actual":589602000.0,"consensus_period":"2023-Q2","consensus_source":"xbrl_only","sentiment":"neutral","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":1961050468.1777778,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":289595,"accession_number":"0000926326-23-000025","cik":926326,"company_name":"OMNICELL, INC.","ticker":"OMCL","form_type":"8-K","filed_at":"2023-07-11T23:59:59+00:00","items":["5.02","9.01"],"status":"ready","headline":"Omnicell appoints Bobby Ghoshal to Board of Directors as independent director","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Board expanded from 9 to 10; Ghoshal elected Class II director, term expiring at 2024 Annual Meeting.","Ghoshal is President of SaaS at ResMed with 30+ years experience in finance, semiconductors, healthcare.","He will serve on Corporate Governance Committee; receives initial RSU award of $160k plus $7.5k for committee role.","Part of ongoing board refreshment; 9 of 10 directors now independent."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"market_cap_usd":1961050468.1777778,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":310458,"accession_number":"0000926326-23-000022","cik":926326,"company_name":"OMNICELL, INC.","ticker":"OMCL","form_type":"8-K/A","filed_at":"2023-06-26T23:59:59+00:00","items":["5.02"],"status":"ready","headline":"Omnicell extends outgoing CFO Peter Kuipers' separation date to August 1, 2023","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Separation date extended from July 1 to August 1, 2023.","Kuipers continues as executive adviser until the new separation date.","Material terms of the expected separation agreement not yet finalized."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.2,"calibrated_materiality_score":0.2,"market_cap_usd":1961050468.1777778,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":310463,"accession_number":"0001104659-23-066011","cik":926326,"company_name":"OMNICELL, INC.","ticker":"OMCL","form_type":"8-K","filed_at":"2023-05-30T23:59:59+00:00","items":["5.02","9.01"],"status":"ready","headline":"Omnicell eliminates CCO and Chief Admin Officer roles; promotes several execs","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Scott Seidelmann, EVP/Chief Commercial Officer, steps down effective June 1, 2023; role eliminated.","Christine Mellon, EVP/Chief Admin & People Officer, steps down effective June 1, 2023; role eliminated.","Corey Manley promoted to EVP, Chief Legal & Administrative Officer with expanded oversight.","Nish Parekh rejoins as SVP/Chief Product Officer; Martha Thorne named SVP, GM of EnlivenHealth.","Minoo Mortazavi promoted to SVP Global Operations; Maximo Rocha promoted to Chief People Officer."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.55,"calibrated_materiality_score":0.55,"market_cap_usd":1961050468.1777778,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":310462,"accession_number":"0000926326-23-000020","cik":926326,"company_name":"OMNICELL, INC.","ticker":"OMCL","form_type":"8-K","filed_at":"2023-05-26T23:59:59+00:00","items":["5.02","5.07","9.01"],"status":"ready","headline":"Omnicell stockholders approve 3M share addition to ESPP and 1.6M to equity plan","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Elected three Class I directors: Joanne B. Bauer, Robin G. Seim, Sara J. White.","Approved amendment to 1997 ESPP adding 3,000,000 shares authorized for issuance.","Approved amendment to 2009 Equity Incentive Plan adding 1,600,000 shares authorized.","Advisory vote on say-on-pay frequency: stockholders favored annual frequency; board adopts annual.","Ratified Deloitte & Touche as independent auditor for FY 2023."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.4,"calibrated_materiality_score":0.4,"market_cap_usd":1961050468.1777778,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":310461,"accession_number":"0001104659-23-060768","cik":926326,"company_name":"OMNICELL, INC.","ticker":"OMCL","form_type":"8-K","filed_at":"2023-05-15T23:59:59+00:00","items":["5.02","9.01"],"status":"ready","headline":"Omnicell appoints Nchacha E. Etta as CFO effective June 1, 2023; Kuipers departing July 1","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Nchacha E. Etta appointed EVP and CFO, effective June 1, 2023, succeeding Peter Kuipers.","Kuipers to serve as executive adviser until July 1, 2023, for transition.","Etta's compensation: $475,000 base salary, $50,000 sign-on bonus, 24,000 RSUs + annual equity awards.","Etta brings 20+ years finance experience from Essilor of America, J&J Vision, Coca-Cola, Microsoft."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.55,"calibrated_materiality_score":0.55,"market_cap_usd":1961050468.1777778,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":310460,"accession_number":"0000926326-23-000011","cik":926326,"company_name":"OMNICELL, INC.","ticker":"OMCL","form_type":"8-K","filed_at":"2023-05-02T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Omnicell Q1 2023 revenue down 9% YoY to $291M, GAAP net loss of $0.33 per share","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Total GAAP revenues $291M (-9% YoY); GAAP net loss $15M ($0.33 loss per share) vs net income $8M ($0.17) prior year.","Non-GAAP net income $17M ($0.39 per share) vs $38M ($0.83) in Q1 2022; non-GAAP EBITDA $27M vs $50M.","Cash and equivalents $340M; total debt $567M; operating cash flow $13M vs -$16M prior year.","Full-year 2023 guidance unchanged: revenue $1.15B-$1.19B, non-GAAP EPS $1.55-$1.80 per share.","Q2 2023 guidance: revenue $278M-$288M, non-GAAP EPS $0.25-$0.35."],"consensus_eps_estimate":null,"consensus_eps_actual":-0.33,"consensus_revenue_estimate":null,"consensus_revenue_actual":290629000.0,"consensus_period":"2023-Q1","consensus_source":"xbrl_only","sentiment":"negative","materiality_score":0.7,"calibrated_materiality_score":0.7,"market_cap_usd":1961050468.1777778,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":310459,"accession_number":"0000926326-23-000009","cik":926326,"company_name":"OMNICELL, INC.","ticker":"OMCL","form_type":"8-K","filed_at":"2023-04-03T23:59:59+00:00","items":["1.01","2.03","9.01"],"status":"ready","headline":"Omnicell amends credit agreement to replace LIBOR with SOFR benchmark","summary_kind":"llm","event_type":"other","confidence":"high","bullets":["Second Amendment to $500M credit agreement replaces LIBOR with SOFR plus 0.10% credit spread adjustment.","Effective March 29, 2023; no change to total commitment amount or financial covenants.","All subsidiary guarantors reaffirmed obligations; no default or event of default occurred.","Borrowing under LIBOR rate no longer permitted after amendment effective date."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.15,"calibrated_materiality_score":0.15,"market_cap_usd":1961050468.1777778,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":329118,"accession_number":"0001104659-23-026700","cik":926326,"company_name":"OMNICELL, INC.","ticker":"OMCL","form_type":"8-K","filed_at":"2023-02-28T23:59:59+00:00","items":["2.02","2.05","5.02","9.01"],"status":"ready","headline":"Omnicell Q4 GAAP loss $0.64; FY2022 revenue up 14%; CFO to step down; cuts 60 jobs","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Q4 GAAP net loss $28M ($0.64 loss per share) vs net income $14M ($0.28) in Q4 2021; FY2022 GAAP net income $6M ($0.12) vs $78M ($1.62) in 2021.","FY2022 total revenues $1.296B (+14% YoY); bookings $1.054B (-13% YoY); backlog $1.215B.","CFO Peter Kuipers to step down effective July 1, 2023; company searching for successor.","Additional restructuring: 60 employees cut, real estate reduction, $13M additional charges; total plan charges $30.5M; expects $50M annualized savings.","FY2023 guidance: revenues $1.15B-$1.19B, non-GAAP EPS $1.55-$1.80, non-GAAP EBITDA $120M-$135M."],"consensus_eps_estimate":null,"consensus_eps_actual":0.12,"consensus_revenue_estimate":null,"consensus_revenue_actual":1295947000.0,"consensus_period":"2022-FY","consensus_source":"xbrl_only","sentiment":"negative","materiality_score":0.85,"calibrated_materiality_score":0.85,"market_cap_usd":1961050468.1777778,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":346745,"accession_number":"0000926326-22-000036","cik":926326,"company_name":"OMNICELL, INC.","ticker":"OMCL","form_type":"8-K","filed_at":"2022-11-30T23:59:59+00:00","items":["2.05"],"status":"ready","headline":"Omnicell to cut 9% of workforce (~350 employees) in restructuring plan","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Plan approved Nov 23, 2022; reduces headcount by ~350 (9% of total workforce).","Estimated nonrecurring charges of ~$17M, primarily cash-based severance and benefits.","Majority of charges expected in Q4 2022; plan to be substantially completed by Q1 2023.","Restructuring driven by expense containment amid ongoing macro-economic headwinds.","Workforce reduction affects majority of functions across the company."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"negative","materiality_score":0.6,"calibrated_materiality_score":0.6,"market_cap_usd":1961050468.1777778,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":346744,"accession_number":"0000926326-22-000031","cik":926326,"company_name":"OMNICELL, INC.","ticker":"OMCL","form_type":"8-K","filed_at":"2022-11-02T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Omnicell Q3 revenue $348M (+17% YoY); GAAP EPS $0.37; guides Q4 revenue $285M-$295M","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["GAAP net income $17M ($0.37/diluted share) vs $29M ($0.61) in Q3 2021.","Non-GAAP net income $45M ($1.00/diluted share) vs $50M ($1.08) YoY.","FY 2022 revenue guidance lowered to $1.284B-$1.294B; non-GAAP EPS $2.73-$2.83.","Q4 revenue forecast $285M-$295M, down sharply from Q3's $348M.","Cites health system capital freezes and labor shortages as headwinds; plans cost structure adjustments."],"consensus_eps_estimate":null,"consensus_eps_actual":0.73,"consensus_revenue_estimate":null,"consensus_revenue_actual":998273000.0,"consensus_period":"2022-Q3","consensus_source":"xbrl_only","sentiment":"negative","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":1961050468.1777778,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":346743,"accession_number":"0000926326-22-000029","cik":926326,"company_name":"OMNICELL, INC.","ticker":"OMCL","form_type":"8-K","filed_at":"2022-10-21T23:59:59+00:00","items":["5.03","9.01"],"status":"ready","headline":"Omnicell adopts amended bylaws for universal proxy rules and DGCL updates","summary_kind":"llm","event_type":"other","confidence":"high","bullets":["Enhanced procedural mechanics for stockholder nominations, including resignation obligations for nominees.","Added requirements for additional disclosures and interviews of proposed nominees.","Addresses Rule 14a-19 universal proxy rules, including intent representation and remedy for non-compliance.","Clarifies board powers to postpone or cancel meetings and chairperson's authority.","Updates provisions to reflect recent Delaware General Corporation Law amendments."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.1,"calibrated_materiality_score":0.1,"market_cap_usd":1961050468.1777778,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":363125,"accession_number":"0001104659-22-101566","cik":926326,"company_name":"OMNICELL, INC.","ticker":"OMCL","form_type":"8-K","filed_at":"2022-09-20T23:59:59+00:00","items":["7.01","9.01"],"status":"ready","headline":"Omnicell unveils 2025 financial targets: $1.9-2.0B revenue, 23% EBITDA margin","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Total revenue target of $1.9-$2.0B by 2025, representing 14-15% CAGR.","Non-GAAP gross margin target of 52-53%; non-GAAP EBITDA margin ~23%.","SaaS/subscription software gross margin target of 65-70% (long-term 70-75%).","Tech-enabled services gross margin target of ~40% (long-term 50-55%).","Advanced Services expected to be 20-30% of total revenue by 2025."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.65,"calibrated_materiality_score":0.65,"market_cap_usd":1961050468.1777778,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":363124,"accession_number":"0001104659-22-101360","cik":926326,"company_name":"OMNICELL, INC.","ticker":"OMCL","form_type":"8-K","filed_at":"2022-09-20T23:59:59+00:00","items":["7.01","9.01"],"status":"ready","headline":"Omnicell holds Investor Day, discusses long-term financial targets and strategy","summary_kind":"llm","event_type":"other_material","confidence":"low","bullets":["Investor Day held September 20, 2022; slides presented are furnished as Exhibit 99.1.","Company discussed Advanced Services portfolio, ESG strategy, and long-term financial targets.","Specific financial targets, numbers, or guidance changes not disclosed in the filing excerpt.","A live webcast and replay are available on the Investor Relations website."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.3,"calibrated_materiality_score":0.3,"market_cap_usd":1961050468.1777778,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":363123,"accession_number":"0000926326-22-000025","cik":926326,"company_name":"OMNICELL, INC.","ticker":"OMCL","form_type":"8-K","filed_at":"2022-08-04T23:59:59+00:00","items":["2.02","8.01","9.01"],"status":"ready","headline":"Omnicell Q2 revenue up 22% to $331M, non-GAAP EPS $0.84; reaffirms FY guidance; ransomware update","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["GAAP revenue $331M (+22% YoY); GAAP EPS $0.20 vs $0.43; non-GAAP EPS $0.84 vs $0.97.","Full-year 2022 guidance reaffirmed: revenue $1.385-1.410B, non-GAAP EPS $3.85-$4.05.","Q3 2022 guidance: revenue $360-366M, non-GAAP EPS $0.93-$1.00.","Ransomware incident impacted Q2; contained with no customer device disruption; <350 individuals notified."],"consensus_eps_estimate":null,"consensus_eps_actual":0.37,"consensus_revenue_estimate":null,"consensus_revenue_actual":650214000.0,"consensus_period":"2022-Q2","consensus_source":"xbrl_only","sentiment":"neutral","materiality_score":0.7,"calibrated_materiality_score":0.7,"market_cap_usd":1961050468.1777778,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":382835,"accession_number":"0000926326-22-000020","cik":926326,"company_name":"OMNICELL, INC.","ticker":"OMCL","form_type":"8-K","filed_at":"2022-05-31T23:59:59+00:00","items":["5.02","5.07","9.01"],"status":"ready","headline":"Omnicell shareholders approve 1.1M additional shares under 2009 equity plan; directors elected","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Shareholders approved amendment to 2009 Equity Incentive Plan authorizing 1,100,000 new shares (For: 35,598,967; Against: 3,678,452).","Class III directors Edward P. Bousa, Bruce E. Scott, and Mary Garrett elected to serve until 2025 annual meeting.","Advisory say-on-pay vote passed with 37,148,931 For vs 2,106,001 Against.","Deloitte & Touche LLP ratified as independent auditor for FY2022 (41,139,882 For)."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.3,"calibrated_materiality_score":0.3,"market_cap_usd":1961050468.1777778,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null}],"next_cursor":"2022-05-31T23:59:59+00:00|382835"}